Previous 10 | Next 10 |
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue PR Newswire Fourth quarter Cell Processing revenue increased 11% sequentially to $14.8 million BOTHELL, Wash. , Jan. 8, 2024 /PRNewswire/ -- BioLife Soluti...
2024-01-06 13:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-29 15:06:19 ET Summary BioLife Solutions, Inc. is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. The company offers bioproduction tools and services for the cell and gene therapy industry, with recurring revenue streams ma...
2023-11-25 17:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-17 17:45:14 ET More on BioLife Solutions BioLife Solutions Q3 2023 Earnings Preview BioLife Solutions expects FY revenue at low end of guidance, names new CEO; shares fall For further details see: BioLife Solutions files to sell 927.2K shares for holders
2023-11-09 22:27:12 ET BioLife Solutions, Inc. (BLFS) Q3 2023 Earnings Conference Call November 09, 2023 04:30 PM ET Company Participants Troy Wichterman - CFO Rod de Greef - Chairman and CEO Conference Call Participants Jacob Johnson - Stephen Matt H...
2023-11-09 16:09:45 ET BioLife Solutions press release ( NASDAQ: BLFS ): Q3 GAAP EPS of -$0.67 misses by $0.29 . Revenue of $33.3M (-18.2% Y/Y) in-line. Continues to expect its full year 2023 revenue, which contains no COVID related revenue, at the low end of the p...
BioLife Solutions Reports Third Quarter 2023 Financial Results PR Newswire Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash. , Nov. 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company")...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
BioLife Solutions Inc. (BLFS) is expected to report $-0.25 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...